Rosenberg Matthew Hamilton Benitec Biopharma Inc. Transaction History

Rosenberg Matthew Hamilton

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$0.2 - $3.53 $71 - $1,263	-358 Reduced 93.96%	23 $0
Q4 2022 Jan 18, 2023	BUY	$0.13 - $5.95 $49 - $2,266	381 New	381 $0
Q2 2022 Jul 15, 2022	SELL	$0.74 - $2.29 $281 - $872	-381 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$3.49 - $4.26 $1,329 - $1,623	381 New	381 $1,000

797K

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $261M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

Stay updated on Rosenberg Matthew Hamilton with notifications on news.